{"id":203,"date":"2017-03-27T14:04:16","date_gmt":"2017-03-27T13:04:16","guid":{"rendered":"http:\/\/inmunologia.webs.uvigo.es\/?page_id=203"},"modified":"2017-08-18T09:27:02","modified_gmt":"2017-08-18T08:27:02","slug":"vaccines","status":"publish","type":"page","link":"https:\/\/inmunologia.webs9.uvigo.es\/?page_id=203","title":{"rendered":"Vaccines"},"content":{"rendered":"

In our group we have worked on different projects for the development of new vaccines in order to characterize the immune response<\/b> produced by them and help to identify new vaccine candidates.<\/p>\n

Our work has been performed in collaboration with other groups with great expertise in the production of different formulations where we test the immunological effects of the prototypes both in vitro<\/em> and in vivo.<\/em><\/p>\n

We have worked on the design of vaccines aimed to treat or prevent different diseases such as Tuberculosis, Type I Diabetes, Multiple Sclerosis, Urine Tract Infection by E. coli<\/em>. Our efforts in the vaccine design were focused on comparing different formulations, vaccine doses and administration routes (intranasal, intramuscular, subcutaneous, etc.) to obtain the best protection possible.<\/p>\n

Many of the prototypes tested in our group are Nanovaccines<\/b> based on nanotechnology (Nanomedicine research line), where we also have performed different nanotoxicity studies to study the potential harm this prototypes may have on the biological systems.<\/p>\n

We also collaborate with different groups to determine\u00a0novel peptide candidates for further design and development of new peptide-based vaccines<\/b> for one of the most frequent causes of food allergies: fish and their parasites.\u00a0To achieve this we are using new approaches like Advanced Proteomics and Systems Biology to characterize the fish and parasite allergens.<\/p>\n

Projects in this research line:<\/h3>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\"\"<\/a>\n\t\t\t\t\t\t

RODAVAC: Deciphering new molecular signatures of vaccine efficacy against \u00abTenacibaculum maritimum\u00bb in turbot (\u00abScophthalmus maxima\u00bb).<\/a><\/h2>\n\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\"\"<\/a>\n\t\t\t\t\t\t

Immunotherapy in pancreatic cancer<\/a><\/h2>\n\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\"\"<\/a>\n\t\t\t\t\t\t

Prote\u00f3mica avanzada y biolog\u00eda de sistemas para el estudio de la alergia alimentaria<\/a><\/h2>\n\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\"\"<\/a>\n\t\t\t\t\t\t

Caracterizaci\u00f3n biol\u00f3gica y f\u00edsico-qu\u00edmica de tres prototipos de nanovacunas<\/a><\/h2>\n\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\"\"<\/a>\n\t\t\t\t\t\t

Eliciting Mucosal Immunity in Tuberculosis (EMI-TB)<\/a><\/h2>\n\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\"\"<\/a>\n\t\t\t\t\t\t

Dise\u00f1o de nanovacunas terap\u00e9uticas basadas en p\u00e9ptidos. Aplicaci\u00f3n al tratamiento de enfermedades autoinmunes (NANOT_AID)<\/a><\/h2>\n\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\"\"<\/a>\n\t\t\t\t\t\t

Nuevas tecnolog\u00edas para vacunas de E. coli (COLIVAC)<\/a><\/h2>\n\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\"\"<\/a>\n\t\t\t\t\t\t

Estudio de la interacci\u00f3n de nanomateriales con ant\u00edgenos: una aproximaci\u00f3n sistem\u00e1tica para el desarrollo de nanovacunas (NANOVAC)<\/a><\/h2>\n\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\n","protected":false},"excerpt":{"rendered":"

Development of new vaccines.
Design of peptide-based therapeutic nanostructures for the treatment and\/or prevention of autoimmune diseases.
Nanovaccines. Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":1,"featured_media":421,"parent":194,"menu_order":20,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-203","page","type-page","status-publish","has-post-thumbnail","hentry"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/pages\/203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=203"}],"version-history":[{"count":9,"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/pages\/203\/revisions"}],"predecessor-version":[{"id":652,"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/pages\/203\/revisions\/652"}],"up":[{"embeddable":true,"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/pages\/194"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/media\/421"}],"wp:attachment":[{"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}